Jonathan D. Root - 05 Oct 2025 Form 4 Insider Report for Omada Health, Inc. (OMDA)

Reporting relationship: Director
Issuer ticker: OMDA
Reported as of: 05 Oct 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Oct 2025, 16:42:40 UTC
Prior SEC filing: 24 Jul 2025
Next SEC filing: 04 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root

Key filing fact

Jonathan D. Root filed Form 4 for Omada Health, Inc. (OMDA) on 07 Oct 2025.

Key facts

This page summarizes Jonathan D. Root's Form 4 filing for Omada Health, Inc. (OMDA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Oct 2025, 16:42.

Change

Previous filing in this sequence was filed on 24 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001225480 Primary reporting owner

ROOT JONATHAN D

Relationship: Director
Address: C/O OMADA HEALTH, INC., 611 GATEWAY BLVD, SUITE 120, SOUTH SAN FRANCISCO
Signature: /s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root
Signature date: 07 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OMDA transaction

Common Stock

Award

Transaction value: $0
Shares: +657
Change %: +6.6%
Price: $0.000000
Shares after: 10,630
Date: 05 Oct 2025
Ownership: Direct
Footnotes: F1

OMDA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,571,769
Date: 05 Oct 2025
Ownership: See footnotes
Footnotes: F2, F3

OMDA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 146,257
Date: 05 Oct 2025
Ownership: See footnotes
Footnotes: F2, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock.

Footnote F2

Presidio Management Group X, L.L.C. ("PMG X"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

Footnote F3

Shares held by U.S. Venture Partners X, L.P.

Footnote F4

Shares held by USVP X Affiliates, L.P.